Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PT Chandra Asri Pacific Tbk, formerly known as PT Chandra Asri Petrochemical Tbk, is Indonesia's largest integrated petrochemical company and a major supplier to the country's manufacturing sector. The company operates the only naphtha cracker in Indonesia, producing essential olefins such as ethylene and propylene, as well as polyolefins like polyethylene and polypropylene. While its chemical products are vital components in the production of medical equipment, personal protective equipment (PPE), and pharmaceutical packaging, the company does not conduct drug discovery or clinical trials. Headquartered in Jakarta with extensive manufacturing facilities in Cilegon, Chandra Asri is a key industrial player in Southeast Asia. Recently, the company has rebranded and expanded its business scope to include infrastructure and energy investments to diversify its portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chandra Asri Petrochemical.